SEC Form 4 · accession 0001127602-16-037021
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paris Panayiotopoulos
Officer — President and CEO · Director
Period of report
Jan 13, 2016
Accepted (ET)
Jan 15, 2016 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $5.34 | Jan 13, 2016 | A | 1,500,000 | A | — | — | Common Stock | 1,500,000 | 1,500,000 | D |
| Restricted Stock UnitsF3,F4 | $0.00 | Jan 13, 2016 | A | 200,000 | A | — | — | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1These options vest as to one fourth of the award on January 13, 2017 and as to one forty-eighth on the award monthly from February 13, 2017 to January 13, 2020.
- F2January 13, 2026
- F3These RSU's vest as to one third of the award on each of July 13, 2016, January 13, 2017 and July 13, 2017.
- F4N/A